Y-L Choi - Korea University Anam Hospital, Korea University College of Medicine

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 72 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 5990: Microtubule-associated Serine/threonine Kinase-Likeinhibitor, AD1208, As a Novel Cancer Therapeutics

SOONGYU CHOI,JS Ahn,KS Baek,YL Choi, MY Im, JH Kim, JW Kim, JH Khoo,SH Lee, WL Yao,Young-Whan Park

Cancer Researchno. 6_Supplement (2024): 5990-5990

引用0浏览0引用

1216P Adjuvant Pembrolizumab Therapy for Completely Resected Stage I NSCLC with Micropapillary or Solid Histological Subtype

S-H. Lee, Y. Bang, S. Park,H-A. Jung,J-M. Sun, J.S. Ahn,M-J. Ahn, Y. Jeon, J. Lee, J.H. Cho, H.K. Kim,Y.S. Choi, Y.M. Shim,Y-L. Choi, J. Han, J. Kim

Annals of Oncology (2024)

引用0浏览0引用

Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow for treatment decisions in non-small cell lung cancer (NSCLC)

J. Lee, S. Park,S-H. Lee,Y-L. Choi,Y-D. Choi, M-G. Noh,J. Park, S. Shin,T. Lee, H. Song,J. Ro, J. Moon, S. Kim,C. Ahn,S. Pereira,D. Yoo,C-Y. Ock

ANNALS OF ONCOLOGY (2023): S1189-S1190

引用0浏览0引用

Nationwide Precision Oncology Pilot Study: KOrean Precision Medicine Networking Group Study of MOlecular Profiling-Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors (KOSMOS) KCSG AL-20-05

T-Y. Kim, S. Y. Kim, J. H. Kim,H. A. Jung,Y. J. Choi,I. G. Hwang, Y. Cha,G-W. Lee,Y-G. Lee,T. M. Kim,S-H. Lee,S. Lee,H. Yun,Y-L. Choi, S. Yoon,S-W. Han,T. W. Kim,D. Y. Zang, J. H. Kang

ANNALS OF ONCOLOGY（2023）

引用0浏览0WOS引用

708P Final Clinical Outcomes of Nationwide Precision Oncology Pilot Study; KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors (KOSMOS) KCSG AL-20-05

T-Y. Kim, S.Y. Kim,J.H. Kim,H.A. Jung,Y.J. Choi,I.G. Hwang,Y. Cha,G-W. Lee,Y-G. Lee,T.M. Kim,S-H. Lee,S. Lee,H. Yun,Y-L. Choi, S. Yoon,S-W. Han,T.W. Kim,D.Y. Zang,J.H. Kang

Annals of oncology (2023): S490-S491

引用0浏览0引用

Abstract PD2-08: Serial genomic profiling reveals molecular mechanisms of breast cancer resistance to palbociclib

Z Kan, Sa Im,K Park,J Wen,Kh Lee,Yl Choi, Wc Lee,A Min,V Bonato

user-61447a76e55422cecdaf7d19（2022）

引用0浏览0引用

5P Exploratory Biomarker Analysis from Neoadjuvant Atezolizumab, Pertuzumab, Trastuzumab Plus Docetaxel (NEO-PATH) in HER2+ Early Breast Cancer

H. K. Ahn, K. Park,S. H. Sim,K. J. Suh, M. H. Kim,W-Y. Park,Y-L. Choi, S-A. Im,K. H. Jung,Y. H. Park

Annals of oncology（2022）

引用0浏览0引用

Adjuvant Durvalumab for Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: a Placebo-Controlled, Randomized, Double-Blind, Phase II Study

S. Park,J-M Sun,Y-L Choi,D. Oh, H. K. Kim,T. Lee, S. A. Chi,S-H Lee,Y. S. Choi,S-H Jung,M-J Ahn,Y. C. Ahn, K. Park,Y. M. Shim

ESMO open（2022）

引用18浏览0WOS引用

OD1-1 Preliminary results from the KOrean precision medicine networking group study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS): KCSG AL-20-05

T-Y. Kim, J.H. Kim,H.A. Jung, Y.J. Choi,I.G. Hwang,Y. Cha,G-W. Lee,Y-G. Lee,M.S. Ahn, T.M. Kim, S-H. Lee, S. Lee,H. Yun,Y-L. Choi,T-Y. Kim, T.W. Kim,D.Y. Zang,J.H. Kang, S.Y. Kim, S. Yoon

ESMO Openno. 6 (2022): 100653-100653

引用0浏览0引用

MET-enriched circulating tumor cells and cell-free DNA concentration as significant independent predictors for progression in HR-positive HER2-negative metastatic breast cancer

J. Park, E. S. Chang,J-Y. Kim, C. Chelakkot, M. Sung,J-Y. Song, K. Jung, N. Y. Kim,Y. H. Park,Y. K. Shin,Y-L. Choi

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn